Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.6.3.44 (
P-glycoprotein
)
13,344
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In the central nervous system, the primary targets of the human immunodeficiency virus-1 (HIV-1) are microglia, resulting in a disorder called HIV-1 dementia.
P-glycoprotein
(
P-gp
), a membrane-associated ATP-dependent efflux transporter, limits entry into the brain of numerous xenobiotics, including anti-HIV drugs (i.e., protease inhibitors). This project investigates the functional expression of
P-gp
in the endogenous immune cells of the brain, a parenchymal compartment not previously studied. We used a cell line (
MLS
-9) derived from rat microglia to study the transport of digoxin, a known
P-gp
substrate. Reverse transcriptase-polymerase chain reaction analysis detected mRNA for only mdr1b in
MLS
-9 cells, whereas both mdr1a and mdr1b mRNA were expressed in primary cultured microglia from which they were derived. Western blot analysis with the C219 antibody detected a single band at ~170 to 180 kDa in
MLS
-9 cells, which is the size previously reported for
P-gp
. Immunocytochemical analysis with the monoclonal antibodies C219, MRK16, and MAB-448 labeled
P-gp
protein along the plasma membrane and nuclear envelope of
MLS
-9 cells. [3H]Digoxin accumulation by monolayers of
MLS
-9 cells was significantly enhanced in the presence of any of several
P-gp
inhibitors (verapamil, cyclosporin A, quinidine, PSC 833), protease inhibitors (i.e., saquinavir, indinavir, and ritonavir), and sodium azide, an ATPase inhibitor. These results provide the first evidence for the functional expression of
P-gp
in microglia and imply that entry of pharmacological agents, including protease inhibitors, may be prevented within the brain parenchyma, as well as at the blood-brain barrier.
...
PMID:Functional expression of P-glycoprotein in rat brain microglia. 1156 Oct 81
The pathogenesis of human immunodeficiency virus (HIV)-associated dementia has been linked to microglial responses after infection. We have recently confirmed expression of several ATP-dependent efflux transporters in microglia, namely, multidrug resistance protein 1 (MRP1) and
P-glycoprotein
(
P-gp
). In the present study, we investigated whether cultured rat microglia express two additional MRP family members, rMRP4 and rMRP5. Using reverse transcriptase-polymerase chain reaction, rMRP4 and rMRP5 mRNA was detected in primary cultures of microglia and in a rat microglia cell line,
MLS
-9. Western blot analysis further confirmed protein expression of the two MRP isoforms in
MLS
-9 cells. Bis(pivaloxymethyl)-9-(2-phosphonylmethoxyethyl)adenine [bis(POM)PMEA], a lipophilic ester prodrug of the well characterized MRP4 and 5 substrate 9-(2-phosphonylmethoxyethyl)adenine (PMEA), was chosen to examine transport characteristics in
MLS
-9. Using thin layer chromatography, we verified that more than 90% of radioactivity recovered in
MLS
-9 loaded with 1 microM [(3)H]bis(POM)PMEA for 1 h under ATP-depleting conditions was converted to PMEA. Efflux of PMEA by
MLS
-9 cell monolayers was ATP-dependent, glutathione-independent, and significantly inhibited by several MRP inhibitors (i.e., sulfinpyrazone, genistein, indomethacin, and probenecid) as well as the antiretroviral drug azidothymidine-monophosphate. Similar results were not observed in MRP1- or
P-gp
-overexpressing cell lines, suggesting that PMEA is not a substrate for either
P-gp
or MRP1. These studies provide further evidence that microglia express multiple subfamilies of ATP-binding cassette transporters (i.e.,
P-gp
, MRP1, MRP4, and MRP5) that could restrict permeation of several different classes of antiretroviral drugs in a brain cellular target of HIV-1 infection.
...
PMID:Multidrug resistance protein (MRP) 4- and MRP 5-mediated efflux of 9-(2-phosphonylmethoxyethyl)adenine by microglia. 1476 2
P-glycoprotein
is a plasma membrane drug efflux protein implicated in extrusion of cytotoxic compounds out of a cell. There is now evidence that suggests expression of this transporter at several subcellular sites, including the nucleus, mitochondria, and Golgi apparatus. This study investigated the localization and expression of
P-glycoprotein
at the nuclear membrane of rat brain microvessel endothelial (RBE4) and microglial (
MLS
-9) cell lines. Immunocytochemistry at the light and electron microscope levels using
P-glycoprotein
monoclonals antibodies demonstrated the localization of the protein at the nuclear envelope of RBE4 and
MLS
-9 cells. Western blot analysis revealed a single band of 170-kDa in purified nuclear membranes prepared from isolated nuclei of RBE4 and
MLS
-9 cells. These findings indicate that
P-glycoprotein
is expressed at the nuclear envelope of rat brain cells and suggest a role in multidrug resistance at this subcellular site.
...
PMID:Localization of P-glycoprotein at the nuclear envelope of rat brain cells. 1765 95